Nitric Oxide와 종양 = Nitric oxide and cancer

다국어 초록 (Multilingual Abstract)

Nitric oxide (NO) is emerging as a potential anti-cancer agent to overcome tumor cell resistance to conventional therapeutic agents. NO is a short-life molecule produced from L-arginine by the nitric oxide synthase (NOS). There are three isoforms of the enzyme: neuronal NOS (nNOS or NOS1), inducible NOS (iNOS or NOS2), and endothelial NOS (eNOS or NOS3). Each of these isoforms may be expressed in a variety of cell types. The actions of NO are highly variable in oncology revealing both sides of the spectrum as an anti-neoplastic versus a pro-neoplastic agent. The final activity of NO is dependent on its working microenvironment, including the type of cell exposed to NO, the redox state of the reaction, as well as the final intracellular concentration and the duration of exposure to NO. NO donors mimic continuous production of NO in a wide range of time intervals (seconds to days). Thus, multiple biological and (pro-versus anti-) neoplastic responses are elicited from NO donors depending on the half-life and the type of cell exposed to the compound. This paper is a review of the current knowledge of various roles of NO in cancer. (Korean J Med 78:430-436, 2010)

참고문헌 (Reference)

1 Messmer UK, "p53 expression in nitric oxide-induced apoptosis" 355 : 23-26, 1994

2 Jansson OT, "The role of nitric oxide in bacillus Calmette-Guérin mediated anti-tumour effects in human bladder cancer" 78 : 588-592, 1998

3 Beckman JS, "The double-edged role of nitric oxide in brain function and superoxide- mediated injury" 15 : 53-59, 1991

4 Moncada S, "The L-arginine-nitric oxide pathway" 329 : 2002-2012, 1993

5 Becker Y, "Success and failure of dendritic cell (DC) anticancer activity may be modulated by nitric oxide synthetase (NOS) gene expression: a hypothesis" 7 : 285-288, 1993

6 Melino G, "S-nitrosylation regulates apoptosis" 388 : 432-433, 1997

7 Jenkins DC, "Roles of nitric oxide in tumor growth" 92 : 4392-4396, 1995

8 Lala PK, "Role of nitric oxide in carcinogenesis and tumour progression" 2 : 149-156, 2001

9 Olson SY, "Regulation of apoptosis-related genes by nitric oxide in cancer" 19 : 170-176, 2008

10 Stamler JS, "Physiology of nitric oxide in skeletal muscle" 81 : 209-237, 2001

11 Salgo MG, "Peroxynitrite causes DNA nicks in plasmid pBR322" 210 : 1025-1030, 1995

12 SoRelle R, "Nobel Prize awarded to scientists for nitric oxide discoveries" 98 : 2365-2366, 1998

13 Kroncke KD, "Nitric oxide: cytotoxicity versus cytoprotection - how, why, when and where?" 1 : 107-120, 1997

14 Brune B, "Nitric oxide. NO apoptosis or turning it ON?" 10 : 864-869, 2003

15 Forrester K, "Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53" 93 : 2442-2447, 1996

16 Messmer UK, "Nitric oxide-induced apoptosis. p53-dependent and p53-independent signalling pathways" 319 : 299-305, 1996

17 Blaise GA, "Nitric oxide, cell signaling and cell death" 208 : 177-192, 2005

18 Bredt DS, "Nitric oxide, a novel neuronal messenger" 8 : 3-11, 1992

19 Song EK, "Nitric oxide synthesis contributes to inhibition of graft-versus-tumor-effects against intraperitoneal Meth A tumor" 230 : 109-118, 2004

20 장광, "Nitric oxide suppresses inducible nitric oxide synthase expression by inhibiting post- translational modification of IκB" 생화학분자생물학회 36 (36): 311-324, 2004

21 Rao CV, "Nitric oxide signaling in colon cancer chemoprevention" 555 : 107-119, 2004

22 Li J, "Nitric oxide reversibly inhibits seven members of the caspase family via Snitrosylation" 240 : 419-424, 1997

23 Chazotte-Aubert L, "Nitric oxide nitrates tyrosine residues of tumor-suppressor p53 protein in MCF-7 cells" 267 : 609-613, 2000

24 Heller R, "Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP" 144 : 49-57, 1999

25 Lau YT, "Nitric oxide inhibits migration of cultured endothelial cells" 221 : 670-674, 1996

26 Zech B, "Nitric oxide donors inhibit formation of the Apaf-1/caspase-9 apoptosome and activation of caspases" 371 : 1055-1064, 2003

27 MacMicking J, "Nitric oxide and macrophage function" 15 : 323-350, 1997

28 Boyd CS, "Nitric oxide and cell signaling pathways in mitochondrial- dependent apoptosis" 383 : 411-423, 2002

29 Oliveira CJ, "Nitric oxide and cGMP activate the Ras-MAP kinase pathway-stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells" 35 : 381-396, 2003

30 Wang Y, "Neuronal NOS: gene structure, mRNA diversity and functional relevance" 13 : 21-43, 1999

31 Shimaoka M, "NOC, a nitric-oxide-releasing compound, induces dose-dependent apoptosis in macrophages" 209 : 519-526, 1995

32 Laurent M, "Kinetic modelling of the nitric oxide gradient generated in vitro by adherent cells expressing inducible nitric oxide synthase" 3141 : 109-113, 1996

33 Bredt DS, "Isolation of nitric oxide synthetase, a calmodulin- requiring enzyme" 87 : 682-685, 1990

34 Zhao J, "Interplay among nitric oxide and reactive oxygen species: a complex network determining cell survival or death" 2 : 544-547, 2007

35 Pipili-Synetos E, "Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate" 116 : 1829-1834, 1995

36 Laval F, "Inhibition by nitric oxide of the repair protein, O6-methylguanine- DNA-methyltransferase" 15 : 443-447, 1994

37 Nathan C, "Inducible nitric oxide synthase: what difference does it make?" 100 : 2417-2423, 1997

38 Kroncke KD, "Inducible nitric oxide synthase in human diseases" 113 : 147-156, 1998

39 Lechner M, "Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin" 15 : 277-289, 2005

40 Mortensen K, "High expression of endothelial cell nitric oxide synthase in peritumoral microvessels predicts increased diseasefree survival in colorectal cancer" 216 : 109-114, 2004

41 Hibbs JB Jr, "Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy" 89 : 867-877, 1992

42 Brennan PA, "Emerging role of nitric oxide in cancer" 37 : 370-373, 1999

43 Yim CY, "Effects of nitric oxide (NO) synthesis inhibition on antitumor responses during interleukin-2 (IL-2) treatment of mice" 11 : 93-100, 1996

44 Wink DA, "DNA deaminating ability and genotoxicity of nitric oxide and its progenitors" 254 : 1001-1003, 1991

45 Nguyen T, "DNA damage and mutation in human cells exposed to nitric oxide in vitro" 89 : 3030-3034, 1992

46 Von KA, "Cyclooxygenase-2: an essential regulator of NO-mediated apoptosis" 11 : 887-895, 1997

47 Xie K, "Contribution of nitric oxide-mediated apoptosis to cancer metastasis inefficiency" 34 : 969-986, 2003

48 Janssens SP, "Cloning and expression of a cDNA encoding human endothelium- derived relaxing factor/nitric oxide synthase" 267 : 14519-14522, 1992

49 Wink DA, "Chemical biology of nitric oxide: insights into regulatory, cytotoxic and cytoprotective mechanisms of nitric oxide" 25 : 434-456, 1998

50 Munder M, "Arginase: an emerging key player in the mammalian immune system" 158 : 638-651, 2009

51 Li CQ, "Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53" 64 : 3022-3029, 2004

52 Kawasaki K, "Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis" 23 : 5726-5737, 2003

53 Zaragoza C, "Activation of the mitogen activated protein kinase extracellular signal-regulated kinase 1 and 2 by the nitric oxide- cGMP-cGMP-dependent protein kinase axis regulates the expression of matrix metalloproteinase 13 in vascular endothelial cells" 62 : 927-935, 2002

54 Glockzin S, "Activation of the cell death program by nitric oxide involves inhibition of the proteasome" 274 : 19581-19586, 1999

55 Laval F, "A discussion of mechanisms of NO genotoxicity: implication of inhibition of DNA repair proteins" 131 : 175-191, 1997